GBGennady Nikolaevich Bisaga

Gennady Nikolaevich Bisaga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gennady Nikolaevich Bisaga has a total of 133 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Results of the scientific and practical conference with international participation «Neurology of the XXI Century: Current Issues, Achievements and Innovations». March 26—27, 2026, St. Petersburg

    by T.M. Alekseeva, G.N. Bisaga, M.P. Topuzova, T.A. Shustova

    This article presents the findings from the fifth scientific and practical conference with international participation entitled «Neurology of the XXI Century: Current Issues, Achievements and Innovations,» held on March 26—27, 2026, in St. Petersburg. The scientific program included plenary sessions, sectional reports, master classes, educational events, and clinical cases presented by participants from both Russia and abroad. The conference attracted over 1.000 specialists. Key topics discussed included vascular pathology of the brain, neurodegenerative diseases, immune-mediated neuromuscular disorders, multiple sclerosis, epilepsy, neuroinfections, pain syndromes, and medical rehabilitation. Special emphasis was placed on the importance of interdisciplinary approaches and personalized medicine. The conference not only highlighted a high standard of scientific and educational engagement but also fostered professional exchange of experiences and pinpointed promising directions for advancing neurology. The next conference is scheduled for spring 2027.

  • Open Access

    Current approaches to multiple sclerosis management in pregnancy

    by Valeriya A. Malko, Ekaterina A. Sadovnichuk, Gennady N. Bisaga

    This article reviews literature data on the impact of multiple sclerosis (MS) on fertility and pregnancy outcomes, the specifics of using disease- modifying therapies (DMTs), and breastfeeding practices. The results demonstrate that fertility rates in women with MS do not differ from the general population, and the frequency of pregnancy complications, including stillbirths, congenital malformations, and spontaneous abortions, does not exceed population-level rates. A reduction in MS activity is observed during the third trimester of pregnancy; however, the risk of relapses increases by 50% within the first three months postpartum, necessitating timely resumption of therapy. Pregnancy management in women with MS should involve interdisciplinary collaboration between neurologists and obstetricians and gynecologists, personalized therapy adjustments, and patient education about safe treatment strategies. Certain DMTs can be safely used during pregnancy and lactation, though careful benefit-risk assessment remains crucial. Women with MS can successfully plan and carry pregnancies to term without significant untoward effects on outcomes. Developing personalized management strategies for these patients will help minimize risks and improve their quality of life.

  • Study of neurodegeneration in multiple sclerosis using optical coherence tomography of the retina and magnetic resonance morphometry of the brain

    by T.V. Shchukina, G.N. Bisaga, V.A. Malko, K.A. Tolochko, M.P. Topuzova, A.YU. Dadatsky, A.YU. Efimtsev, A.S. Lepekhina, I.A. Turchinskaya, T.M. Alekseeva

    Objective. To search and study the relationship between the change in the thickness of the retinal ganglionic complex layers and the volumetric indicators of the brain in patients with multiple sclerosis (MS). Materials and methods. Fifty-seven MS patients aged 19 to 68 years (mean age 39.6±11.2 years) were examined with a diagnosis confirmed by the 2017 McDonald criteria and no previous history of optic neuritis. All patients underwent MRI brain morphometry, optical coherence tomography (OCT) of the retina, and an Expand Disability Status Scale (EDSS) assessment. Results. A direct correlation was found between the thickness of most layers of the “internal” retina and the total volume of white and gray matter of the telencephalon, nuclei accumbens, pallidum, ventral diencephalon, superior parietal gyrus, thalamus, and inversely with the size of the ventricular system of the brain, subcallosal zone, total volume of cerebrospinal fluid (CSF), and foci of brain lesion. The transverse size of the ganglion cell layer (GCL) correlated most with the volumetric parameters of the brain: with the volumes of gray (r=0.426; p=0.001) and white (r=0.564; p<0.000) matter, the nucleus accumbens (r=0.841; p<0.000), thalamus (r=0.542; p=0.000), CSF (r=–0.601; p<0.000), and cingulate gyrus (r=0.304; p=0.002). A less distinct correlation was found between the brain parameters and the thickness of the ganglion cell layer and the inner plexiform layer (GCIPL) with volumes of gray (r=0.389; p=0.002) and white (r=0.439; p=0.000) matter, nucleus accumbens (r=0.463; p=0.000), thalamus (r=0.447; p=0.000), CSF (r=–0.518; p<0.000), cerebellum (r=0.331; p=0.012), and peripapillary retinal nerve fiber layer (pRNFL) with volumes of white matter (r=0.419; p=0.001), nucleus accumbens (r=0.421; p=0.001), thalamus (r=0.396; p=0.002), CSF (r=–0.368; p=0.004), and hippocampus (r=0.399; p=0.002). A significant positive correlation was found between the thickness of the macular retinal nerve fiber layer (mRNFL) and cerebellar volumetric parameters (r=0.351; p=0.007). Conclusion. The anatomical and pathological structure of the eye’s retina reflects the neurodegeneration of the central nervous system as a whole. The most sensitive markers of regional gray matter atrophy of the brain are macular thickness in GCL and GCIPL, as well as pRNFL.

  • Challenges of differential diagnosis in the verification of Behçet’s disease with neurological manifestations

    by A.I. Vlasenko, M.P. Topuzova, V.A. Malko, G.N. Bisaga, T.A. Pavlova, A.P. Abramova, A.O. Chistyakova, T.M. Alekseeva

    Behçet’s disease (BD) is an autoimmune vasculitis of unclear etiology characterized by a wide range of systemic manifestations. The nervous system is involved in approximately 10% of patients with BD (neuro-Behçet). Diagnosis of neuro-Behçet is challenging, especially in the case of BD onset with neurological manifestations, and is based on a combination of clinical, laboratory, and neuroimaging data. To verify the diagnosis of neuro-Behçet, a wide range of conditions with similar manifestations must be ruled out: multiple sclerosis, neuromyelitis optica spectrum disorder, neurosarcoidosis, and many rare autoimmune diseases (e.g., Cogan syndrome, Susac syndrome, Vogt-Koyanagi-Harada syndrome). This article presents a brief literature review highlighting the challenges of neuro-Behçet differential diagnosis and a clinical case of a 34-year-old male patient with a criteria-based diagnosis of BD with neurological manifestations.

  • Preservation of pelvic organ functions after surgical treatment of tumors in the caudal section of the spinal cord: role of intraoperative neurophysiological monitoring

    by Dar’yA Е. Malyshok, Gennadiy N. Bisaga, Аndrei Yu. Оrlov, Mikhail V. Aleksandrov

    The effectiveness of intraoperative neurophysiological monitoring of the segmental apparatus for the regulation of pelvic functions during surgical treatment of tumors in the caudal spinal cord was assessed. In this study, 99 patients with extramedullary and intramedullary spinal cord tumors at the Th11–S5 vertebral levels who received neurosurgical treatment were examined. Based on the extent of intraoperative neurophysiological monitoring, patients were divided into two groups: group 1 underwent standard monitoring of the pyramidal system, and group 2 underwent extended monitoring of pelvic organ functions, which was based on the recording of the bulbocavernosus reflex. Neurological examinations were conducted for all patients before surgery and in the early postoperative period (10–14 days). Twelve months after the surgery, a telephone survey of the complaints of pelvic organ dysfunction was conducted. The surgical outcomes of both groups were compared. Pelvic organ dysfunctions in the preoperative period were identified in 25%–30% of the patients in each group. In the examination 10–14 days after surgery, pelvic organ dysfunctions were found in 20 (48.8%) patients in group 1 and in 16 (27.6%) in group 2. At 12 months after surgery, the dysfunction rate increased from 56.1% (n = 23) in group 1 to 29.3% (n = 17) in group 2. Non-monitoring increased the risk of pelvic organ dysfunctions by 2.5 times in the early postoperative period (odds ratio, 2.50 (1.07–5.79)) and 3.08 times after 1 year (odds ratio, 3.08 (1.35–7.11)). Monitoring of pelvic functions reduced the risk of pelvic organ dysfunctions first identified in the early postoperative period by 5.2 times (odds ratio, 0.192 (0.04–0.80)). Thus, intraoperative continuous monitoring of the state of the segmental apparatus for regulating pelvic functions helps minimize the risk of postoperative development of pelvic disorders in patients with tumor lesions of the caudal parts of the spinal cord. Pelvic monitoring increases the functional permissibility of the operation, maintaining or improving the quality of life of the patients.

  • Optical coherence retinal tomography as a prognostic biomarker of multiple sclerosis progression

    by T. V. Shchukina, G. N. Bisaga, В. А. Малько, M. P. Topuzova, K. A. Tolochko, A. Yu. Dadatsky, T. M. Alekseeva, А. Ю. Дадацкий

    Multiple sclerosis is an autoimmune infl ammatory demyelinating neurodegenerative disabling disease of the central nervous system of multifactorial genesis. In the initial stages of remitting multiple sclerosis, autoimmune inflammation prevails with alternation of exacerbations and remissions, but, subsequently, progressive neurodegeneration develops, which underlies the persistent disability of patients. The transition of remitting multiple sclerosis into a secondary progressive form is a critical factor for long-term prognosis and makes it necessary to find accurate biomarkers, predictors of the risk of transformation of MS. One such marker is the thickness of the nerve fiber layer and ganglion cells, as well as the condition of the retinal microvasculature, which is easily verifi ed by optical coherence tomography (OCT), a non-invasive method that allows for real-time retinal segmentation in the axial plane.   The aim of this review is to discuss the results achieved in the study and application OCT of the retina as a potential imaging biomarker of multiple sclerosis progression.


  • Possibilities of magnetic resonance morphometry and laboratory biomarkers in studying the progression of multiple sclerosis

    by V.A. Malko, E.A. Sadovnichuk, A.S. Lepekhina, G.N. Bisaga, M.P. Topuzova, T.V. Shchukina, N.V. Dryagina, A.YU. Efimcev, T.M. Alekseeva

    Objective. To show that magnetic resonance morphometry and laboratory biomarkers are promising methods for early detection of progressive forms of multiple sclerosis (MS). Material and methods. Eighty-one patients with MS were examined, magnetic resonance morphometry was performed in all of them, 60 patients were analyzed for neurofilament light chains (sNFL), phosphorylated neurofilament heavy chains (spNFH) and glial fibrillary protein (sGFAP) in serum by enzyme-linked immunosorbent assay. Results. Brain volumes were negatively correlated with disease duration, EDSS score, 25-foot walk test score and 9-ring test and positively correlated with the Symbol-Numeric Test and the Montreal Cognitive Assessment. Patients with progressive types of MS (PMS) had smaller volumes of brain gray matter, cerebellar white matter, occipital lobes, caudate nucleus, hippocampus, pallidum, thalamus, and contiguous nucleus. A CSF volume greater than 15.06% could suggest progression (CI 54.79—91%) with a sensitivity of 77.78% and specificity of 70.18%. When patients were on DMT, they had larger thalamic volumes (median 1.09% [1.6; 1.16] vs 1.04% [0.95; 1.14]; p=0.02) and smaller CSF volumes (13.86±2.87% vs. 15.55±3.49%; p=0.03). The levels of sNFL and spNFH were not increased in PMS and during exacerbations, and the low obtained values of sNFL suggest poor sensitivity of the method. There were trends (p=0.374) towards higher sGFAP in patients with PRS (median 3.2 ng/mL [1.85; 4.6] compared to remitting MS (2.05 ng/mL [1.29; 4.52]). Conclusion. The results demonstrate the differences in brain volumes in patients with different types of MS and emphasize the importance of long-term follow-up to better assess disease progression.


  • Open Access

    A central vein sign in the magnetic resonance diagnosing of multiple sclerosis

    by E. A. Potemkina, I. A. Turchinskay, A. Yu. Efimtsev, A. G. Trufanov, G. N. Bisaga, A. Yu. Polushin, V. V. Volgina, А. Ю. Ефимцев

    Background. Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease, which is characterized by the inevitable disability of patients in the long term, which determines the relevance of this problem. Currently, active improvements are being made in the methods of diagnosing multiple sclerosis, which include the use of the central vein sign in magnetic resonance imaging (MRI) as a neuroimaging biomarker of MS with high sensitivity and specificity.Aim of study. Determination of the possibility of assessing the central vein sign (CVS) according to MRI data as a potential diagnostic biomarker of MS.Object and methods. An open single-center prospective study of brain MR data was conducted in 55 patients with a verified diagnosis of MS (EDSS 1.0-6.5) aged 19 to 72 years. MR-images were obtained on a tomograph with a magnetic field induction force of 3.0 T. Patients underwent MRI of the brain according to the standard protocol: T2-VI, FLAIR, T1-VI (before and after administration of contrast agent), SWI. A comprehensive statistical analysis and evaluation of the obtained MRI data was performed using the Statistica 12 program.Result. During the evaluation of MR-tomograms, all patients with a verified diagnosis in the foci of MS were found to have CVS. In 14.5 % of patients, CVS was detected in 10-30 % of foci, in 61.8 % of patients in 30-60 %, in 23.6 % of patients, from 60 to 95 % was detected. Accordingly, 52.7 % of patients overcame the threshold value of 45 % required for the differential diagnosis of MS from other conditions.Conclusion. The use of CVS in MRI helps to solve the problem of differential diagnosis of MS from other demyelinating diseases when using its threshold criterion – the percentage of foci containing central veins.

  • Open Access

    Changes in DNMT1 expression as a marker of epigenetic regulation disturbanses in multiple sclerosis patients

    by Evgenia A. Tsymbalova, Ekaterina А. Chernyavskaya, Darja Е. Ryzhkova, Gennady N. Bisaga, Irina N. Abdurasulova, Viktoria I. Lioudyno, Цымбалова Евгения Антоновна, Людыно Виктория Иосифовна

    BACKGROUND: Multiple sclerosis is a chronic neurodegenerative autoimmune disease characterized by the presence of foci of inflammation and demyelination in the central nervous system. The initiation of pathological processes in multiple sclerosis is caused by a complex interaction of genetic factors, unfavorable environmental factors and epigenetic influences. Progressive neurological symptoms caused by axonal conduction disorders, axonal death and neurodestruction lead to a significant decreased patients’ quality of life and disability. The search for a new markers to improve diagnostic and therapeutic methods, including taking into account the genetic background and epigenetic interactions, is an urgent task. AIM: The work was aimed to study the changes in DNMT1 mRNA expression in multiple sclerosis patients with different disease duration, to analyze methylation of DNMT1 promoter, and compare the changes in the level of DNMT1 expression with the homocysteine content in the blood, and the presence of polymorphic variants in genes coding the key folate cycle enzymes. MATERIALS AND METHODS: The level of DNMT1 mRNA expression in peripheral mononuclear blood cells was assessed by reversed transcription followed by polymerase chain reaction. Fluorescent polymerase chain reaction followed by methyl-sensitive analysis of high-resolution melting curves was used to analyze methylation of the DNMT1 promoter. The content of homocysteine in the blood was determined by chemiluminescence immunoassay. The real-time polymerase chain reaction was used for genotyping by polymorphism of folate cycle genes; the fluorescent probes with the LNA modifications were used to discriminate alleles. RESULTS: It has been shown that in multiple sclerosis patients, including those at the onset of the disease, the level of DNMT1 mRNA expression is significantly lower than in the control group. No relationship was found between the decrease in DNMT1 expression and the level of promoter methylation. Strong positive relationship between the level of DNMT1 mRNA expression and homocysteine content in patients with multiple sclerosis and the combined effects of the genotypes of MTR A2756G and MTHFR C677T polymorphism on the expression of DNMT1 have been shown. These findings suggest that genetically determined features of folate metabolism may contribute to the disruption of epigenetic regulation in multiple sclerosis. CONCLUSIONS: The obtained results indicate the promise of research aimed to identifying the factors causing epigenetic changes in multiple sclerosis. Studying the mechanisms of the folate cycle genes polymorphic variants contribution to the pathogenesis of multiple sclerosis could be one of the possible ways to improve diagnostic and therapeutic approaches.